NewAmsterdam Pharma Co N.V.

Ownership Transactions Reported by 20 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+1.65M	47.9%	$24.45	+$40.4M
Sells	4	-1.8M	52.1%	$24.50	-$44.1M
Net	-2	-148K	-4.3%		-$3.7M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
ForGrowth NAP B.V.	10%+ Owner	$272M	-$30M	-9.94%	Dec 30, 2024
Bain Capital Life Sciences Investors, LLC	10%+ Owner	$239M	+$40M	+20.1%	Dec 13, 2024
James N. Topper	Director	$164M	+$405K	+0.25%	Sep 15, 2025
Michael H. Davidson	Chief Executive Officer, Director	$9.76M			Mar 26, 2025
Johannes Jacob Pieter Kastelein	Chief Scientific Officer, Director	$1.77M	-$2.47M	-58.3%	Aug 21, 2025
William Jones	Chief Commercial Officer	$1.1M			Jan 7, 2025
Michael F. Marino III	Chief Legal Officer and Corporate Secretary	$1.04M			Jun 1, 2025
Douglas F. Kling	Chief Operating Officer	$928K	-$4.03M	-81.3%	Jul 15, 2025
Louis G. Lange	Director	$533K			Jun 1, 2025
Juliette Berangere Audet	Chief Strategy and Business Officer	$386K			May 1, 2025
Louise Kooij	Chief Accounting Officer	$376K	-$7.59M	-95.3%	Sep 9, 2025
Mayur Ian Somaiya	Chief Financial Officer	$352K			Jan 27, 2025
Adele M. Gulfo	Director	$244K			Apr 15, 2025
John W. Smither	Director	$178K			Jan 6, 2025
Mark C. McKenna	Director	$178K			Jan 6, 2025
William Lewis	Director	$178K			Jan 6, 2025
Hilde Johanna van der Kamp	Director	$178K			Jan 6, 2025
Hugo Alexander Slootweg	Director				Dec 29, 2023
Wouter Joustra	Director				Jul 16, 2024
Nicholas Downing	Director				Dec 29, 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.